Off-Label Ozempic, More ‘Twitter Files,’ & Amazon’s Foray into Social 12/09/22

Diabetes drug Ozempic has appealed to celebrities and influencers seeking weight loss, and the pharmaceutical “diet” is riding a TikTok, Twitter, and Instagram wave. Former FDA Commissioner Dr. Scott Gottlieb says, while it may be effective for some, the risks and side effects could be more likely in patients taking it off-label. The ‘Twitter Files’ saga continues, as more internal documents from the social media platform emerge publicly. Representative Ro Khanna (D-CA) addresses the next steps for regulating tech and Sam Bankman-Fried’s decision to testify at FTX’s upcoming hearing. Plus, Amazon has launched a TikTok-style feed of content, Arizona Senator Kyrsten Sinema is leaving the Democratic Party to become Independent, and pet-owners are pushing Chewy’s stock higher. In this episode: Scott Gottlieb @ScottGottliebMD Ro Khanna @RoKhanna Becky Quick @BeckyQuick Joe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkin Katie Kramer, @Kramer_Katie